Literature DB >> 21170069

Why do we need a trial on the effects of testosterone therapy in older men?

N L Cook1, S Romashkan.   

Abstract

Decreases in levels of sex hormones occur with aging. Observational studies have found associations of low testosterone concentrations in older men with adverse symptoms; however, these associations do not prove causality. Therefore, the question arises whether to treat older men whose serum testosterone is low. In 2009, the Testosterone Trial (T Trial) was funded to examine the efficacy of therapy in 800 elderly men with low testosterone levels; potentially associated symptoms; and abnormalities in physical, sexual, or cognitive function or vitality.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21170069     DOI: 10.1038/clpt.2010.217

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN: 0009-9236            Impact factor:   6.875


  2 in total

1.  Ca2+/Calmodulin-Dependent Protein Kinase II and Androgen Signaling Pathways Modulate MEF2 Activity in Testosterone-Induced Cardiac Myocyte Hypertrophy.

Authors:  Javier Duran; Daniel Lagos; Mario Pavez; Mayarling F Troncoso; Sebastián Ramos; Genaro Barrientos; Cristian Ibarra; Sergio Lavandero; Manuel Estrada
Journal:  Front Pharmacol       Date:  2017-09-11       Impact factor: 5.810

2.  Testosterone activates glucose metabolism through AMPK and androgen signaling in cardiomyocyte hypertrophy.

Authors:  Mayarling Francisca Troncoso; Mario Pavez; Carlos Wilson; Daniel Lagos; Javier Duran; Sebastián Ramos; Genaro Barrientos; Patricio Silva; Paola Llanos; Carla Basualto-Alarcón; B Daan Westenbrink; Sergio Lavandero; Manuel Estrada
Journal:  Biol Res       Date:  2021-02-05       Impact factor: 5.612

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.